Category / Product: SERVICES, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Region: Europe

CONTENT GROUP
COC Farmaceutici srl: Sitz; Produktionsstätte.
Category / Product: COSMETICS, ANALYTISCHE CRO, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Batch Size: Large, Medium
Markets: EMA (EU)
Compliance: ISO, EMA (EU GMP)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (S) Sensory organs, (R) Respiratory system
Region: Europe

CONTENT GROUP
COC Farmaceutici srl: Handels- und Verwaltungssitz; Produktionsstätte.
Category / Product: COSMETICS, ANALYTISCHE CRO, FDF / DRUG PRODUCTS
Batch Size: Large, Medium
Markets: EMA (EU), MHRA (UK), EDE (UAE), SFDA (Saudi Arabia)
Compliance: ISO
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Region: Europe

Batch Size: Large, Medium
Compliance: TITCK (Turkish Health Authorities), ANVISA (Brazil B-GMP), FDA (cGMP), TGA (Australia GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP)
Markets: EMA (EU), Russian Health Authorities, FDA (USA), ANVISA (Brazil), TGA (Australia)
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (S) Sensory organs
Category / Product: ANALYTISCHE CRO, FDF / DRUG PRODUCTS
Region: Europe

53Biologics
53Biologics ist ein End-to-End-CDMO für Biologika, das darauf ausgelegt ist, den Fortschritt von der präklinischen bis zur kommerziellen Versorgung voranzutreiben. Dafür sind wir geschaffen.
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Compliance: ISO, FDA (cGMP), World Health Organization (GMP / HACCP), EMA (EU GMP)
Markets: FDA (USA), Health Canada (Canada), ANMAT (Argentina), COFEPRIS (Mexico), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), MSPAS (Guatemala), INVIMA (Colombia), MHRA (UK), EMA (EU), TGA (Australia)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services
Use: Human, Veterinary
Region: Europe
Category / Product: BIOLOGICS

Bilthoven Biologicals BV
GMP-Anlagen für mehrere Produkte für Arzneimittelsubstanzen und Arzneimittelprodukte.
Markets: EMA (EU), MHRA (UK)
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Compliance: EMA (EU GMP)
Category / Product: FDF / DRUG PRODUCTS, ANALYTISCHE CRO, BIOLOGICS
Region: Europe

Arcinova - A Quotient Sciences Company
Arcinova beschleunigt die Arzneimittelentwicklung von der frühen Entdeckung bis zum Proof of Concept und darüber hinaus.
Compliance: FDA (cGMP), ICH, MHRA (UK GMP), EMA (EU GMP)
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada (Canada), MHRA (UK)
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, Narcotic, High potential for abuse & medical use
Batch Size: Small
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: FDF / DRUG PRODUCTS, ANALYTISCHE CRO, CHEMICAL-SYNTHETIC
Region: Europe

Seacross Pharmaceutical Co Ltd
Das Forschungs- und Entwicklungszentrum spielt eine grundlegende Rolle bei der Unterstützung der Entwicklung sowohl von Wirkstoffen als auch von fertigen Darrei
Markets: ISP (Chile), MSPAS (Guatemala), FDA (USA), COFEPRIS (Mexico), DIGEMID (Peru), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), Russian Health Authorities, SFDA (Saudi Arabia), ANMAT (Argentina), CDSCO (India), MFDS (South Korea), INVIMA (Colombia), Turkish Health Authorities, EDE (UAE), TGA (Australia), Rest der Welt
Batch Size: Large, Small, Medium
Compliance: FDA (cGMP), DIGEMID, BRCGS, ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, INVIMA, TGA (Australia GMP), TITCK (Turkish Health Authorities), ECOVADIS, ISP (Chile BPM), French Service-Public (CIR), Health Canada (Canada GMP), MHRA (UK GMP), ANMAT (Argentina nueva GMP), World Health Organization (GMP / HACCP), EMA (EU GMP), NMPA (China GMP), MFDS/KFDA (Republic of Korea GMP), NSF, SQF (Safe Quality Food), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
BSL (Biological Safety Level): 1, 2, 3, 4
Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (N) Nervous system, (S) Sensory organs, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Region: APAC

CZ Vaccines
Einrichtung für klinische Studien
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Markets: EMA (EU), ANVISA (Brazil), CDSCO (India)
Use: Human
BSL (Biological Safety Level): 1, 2
Compliance: ISO, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), EMA (EU GMP)
Batch Size: Small
Category / Product: FDF / DRUG PRODUCTS, BIOLOGICS
Therapeutic Areas of Expertise (ATC): (R) Respiratory system, (G) Genito urinary system and sex hormones, (A) Digestive tract and metabolism
Region: Europe

Aenova
Kompetenzzentrum niedrig dosierte hochwirksame Feststoffe (Hormone, hormonähnlich), niedrig dosierte Kapseln.
Use: Human, Veterinary
Markets: FDA (USA), EMA (EU), ANVISA (Brazil), Russian Health Authorities, MFDS (South Korea), Turkish Health Authorities
Services: Development services, Analytical / QC services, Regulatory services, Packaging, Manufacturing services, Quality Assurance services
Batch Size: Large, Small, Medium
Compliance: FDA (cGMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: FDF / DRUG PRODUCTS
Therapeutic Areas of Expertise (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins
Region: Europe

Seacross Pharmaceutical Co Ltd
Der Standort zur Herstellung von Formulierungen widmet sich der Entwicklung und Produktion komplexer, hochwertiger Darreichungsformen.
Markets: Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), DIGEMID (Peru), MHRA (UK), Russian Health Authorities, CDSCO (India), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), TGA (Australia), Rest der Welt
Batch Size: Large, Small, Medium
Use: Human
BSL (Biological Safety Level): 1, 2, 3, 4
Compliance: ISO, FDA (cGMP), DIGEMID, BRCGS, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, TGA (Australia GMP), TITCK (Turkish Health Authorities), INVIMA, ECOVADIS, ISP (Chile BPM), French Service-Public (CIR), World Health Organization (GMP / HACCP), NMPA (China GMP), Health Canada (Canada GMP), MHRA (UK GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), NSF, SQF (Safe Quality Food), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: FDF / DRUG PRODUCTS, ANALYTISCHE CRO
Region: APAC

Aenova
Kompetenzzentrum Tiergesundheitsprodukte und Steriltechnik.
Markets: ANVISA (Brazil), FDA (USA), EMA (EU), Russian Health Authorities, Turkish Health Authorities, SFDA (Saudi Arabia)
Batch Size: Large, Small, Medium
Use: Human, Veterinary
BSL (Biological Safety Level): 1, 2
Compliance: FDA (cGMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), EMA (EU GMP), SFDA (Saudi Food & Drug Authority)
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: FDF / DRUG PRODUCTS
Region: Europe
Register to unlock the full catalog with contact details and locations.
+70 more facilities
Create free accountSind Sie ein pharmazeutisches Unternehmen und suchen einen zuverlässigen CMO- oder CDMO-Partner, um Ihren Arzneimittelentwicklungsprozess zu beschleunigen? Suchen Sie nicht weiter als MAI CDMO Network. Unsere fortschrittliche Suchplattform verbindet Sie mit einem umfangreichen Netzwerk von qualifizierten Auftragsherstellern und Entwicklungsorganisationen weltweit.
Warum MAI CDMO Network wählen?
So funktioniert MAI CDMO Network
Die wichtigsten Vorteile einer Partnerschaft mit einer CMO/CDMO
Ausgewählte Dienstleistungen
Sind Sie bereit, Ihren idealen CMO/CDMO-Partner zu finden? Jetzt registrieren
Erkunden Sie noch heute unsere Plattform und entdecken Sie, wie MAI CDMO Network Ihnen helfen kann, Ihre Ziele in der Arzneimittelentwicklung zu erreichen.